HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
AD Shapiroa, A Abrahamb, S Linaric, JS Neergaardd, J Odgaard-Jensend, JJT Zawd, H Trane, GG Fabbronf
a Indiana Hemophilia & Thrombosis Center, Indianapolis, United States
b Department of Haematology, Christian Medical College, Vellore, India
c Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy
d Novo Nordisk A/S, Søborg, Denmark
e Haemophilia Treatment Centre, The Alfred Hospital, Melbourne, Australia
f Novo Nordisk Brasil, São Paulo, Brazil
Lido
953
Vezesque se leu este artigo
353
Total PDF
600
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 25 | 12 | 37 |
| 2025 5 | 58 | 17 | 75 |
| 2025 4 | 37 | 12 | 49 |
| 2025 3 | 49 | 11 | 60 |
| 2025 2 | 45 | 15 | 60 |
| 2025 1 | 35 | 25 | 60 |
| 2024 12 | 25 | 9 | 34 |
| 2024 11 | 38 | 15 | 53 |
| 2024 10 | 26 | 17 | 43 |
| 2024 9 | 41 | 20 | 61 |
| 2024 8 | 24 | 15 | 39 |
| 2024 7 | 28 | 22 | 50 |
| 2024 6 | 36 | 23 | 59 |
| 2024 5 | 40 | 31 | 71 |
| 2024 4 | 29 | 13 | 42 |
| 2024 3 | 22 | 17 | 39 |
| 2024 2 | 13 | 20 | 33 |
| 2024 1 | 6 | 8 | 14 |
| 2023 12 | 11 | 23 | 34 |
| 2023 11 | 10 | 19 | 29 |
| 2023 10 | 2 | 9 | 11 |
Mostrar tudo
